CompletedPhase 4NCT05098249

Ferric Carboxymaltose With or Without Phosphate Substitution for the Treatment of Iron Deficiency or Iron Deficiency Anemia

Studying Autosomal recessive sideroblastic anemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Donat R. Spahn
Principal Investigator
Donat R Spahn, Prof. Dr.
University of Zurich
Intervention
Verum(drug)
Enrollment
92 enrolled
Eligibility
18 years · All sexes
Timeline
20212023

Study locations (1)

Collaborators

University of Zurich

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05098249 on ClinicalTrials.gov

Other trials for Autosomal recessive sideroblastic anemia

Additional recruiting or active studies for the same condition.

See all trials for Autosomal recessive sideroblastic anemia

← Back to all trials